Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
Baxter
Boehringer Ingelheim
Medtronic

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Dasotraline


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Dasotraline?

Dasotraline is an investigational drug.

There have been 12 clinical trials for Dasotraline. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2014.

The most common disease conditions in clinical trials are Hyperkinesis, Attention Deficit Disorder with Hyperactivity, and Disease. The leading clinical trial sponsors are Sunovion and [disabled in preview].

There are thirty-eight US patents protecting this investigational drug and two hundred and sixty-eight international patents.

Recent Clinical Trials for Dasotraline
TitleSponsorPhase
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.SunovionPhase 3
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating DisorderSunovionPhase 3
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver DysfunctionSunovionPhase 1

See all Dasotraline clinical trials

Clinical Trial Summary for Dasotraline

Top disease conditions for Dasotraline
Top clinical trial sponsors for Dasotraline

See all Dasotraline clinical trials

US Patents for Dasotraline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dasotraline ⤷  Sign up for a Free Trial Preparation of chiral amides and amines SUNOVION PHARMACEUTICALS INC. (Marlborough, MA) ⤷  Sign up for a Free Trial
Dasotraline ⤷  Sign up for a Free Trial Dosage of dasotraline and method for treatment of ADHD SUNOVION PHARMACEUTICALS INC. (Marlborough, MA) ⤷  Sign up for a Free Trial
Dasotraline ⤷  Sign up for a Free Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Sign up for a Free Trial
Dasotraline ⤷  Sign up for a Free Trial Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Sign up for a Free Trial
Dasotraline ⤷  Sign up for a Free Trial 5-HT2C receptor agonists and compositions and methods of use Arena Pharmaceuticals, Inc. (San Diego, CA) ⤷  Sign up for a Free Trial
Dasotraline ⤷  Sign up for a Free Trial Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine SUNOVION PHARMACEUTICALS INC. (Marlborough, MA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dasotraline

Drugname Country Document Number Estimated Expiration Related US Patent
Dasotraline Australia AU2007233041 2026-03-31 ⤷  Sign up for a Free Trial
Dasotraline Canada CA2648121 2026-03-31 ⤷  Sign up for a Free Trial
Dasotraline China CN101421228 2026-03-31 ⤷  Sign up for a Free Trial
Dasotraline China CN103588659 2026-03-31 ⤷  Sign up for a Free Trial
Dasotraline Denmark DK2013835 2026-03-31 ⤷  Sign up for a Free Trial
Dasotraline Denmark DK2816024 2026-03-31 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
Baxter
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.